Medable is taking its digital clinical trial platform to new heights: the Google Cloud Marketplace. Through the collaboration, Google Cloud’s infrastructure and AI features will be integrated into ...

The Lupus Foundation of America has partnered with Carebox, the leading software platform for clinical trial patient recruitment, to launch the Lupus Clinical Trial Finder, a free platform available ...

According to BCC Research, AI is speeding up clinical development with smarter recruitment, better analytics, and real-time ...

Bio-Optronics — a producer of software and services focused on clinical research, automated scheduling, and patient safety — has announced $30 million in funding from growth equity firm Mainsail ...

eWEEK content and product recommendations are editorially independent. We may make money when you click on links to our partners. Learn More. Phase Forward, a startup provider of data management ...

Today, Revvity, Inc. announced that its software and informatics division, Revvity Signals, is unveiling the Signals Clinical TM solution, a software-as-a-service (SaaS), end-to-end clinical data ...

The "AI-based Clinical Trials Market - Global Forecast 2026-2032" has been added to ResearchAndMarkets.com's offering. The AI-based clinical trials market is driving a fundamental transformation in ...

Teckro, a Limerick, Ireland-based maker of clinical trial software, has raised $25 million in Series C funding, bringing the company’s total backing to $43 million. TechCrunch, Reuters and others ...

The pandemic significantly changed how we do medical research, and now companies are trying to figure out what trends will stay and which ones will go. One that 4G Clinical is hoping will survive the ...

In today’s globalized pharma environment, technical and supply chain challenges in the clinical trial process create ripple effects felt by stakeholders across regions and functions. This has created ...

Clinical software developer PhaseV is teaming up with another global CRO, unveiling a plan to infuse its trial design platform into Bioforum’s services. PhaseV’s Trial Optimizer uses machine learning ...

ATH-063 is a novel, oral, first-in-class, small molecule therapeutic targeting both inflammation and direct mucosal healing in patients with ulcerative colitis and Crohn's disease LOS ANGELES, CA / ...